-20℃ 3 years powder
-80℃ 2 years in solvent
CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | 60.00 | |
5 mg | In stock | 102.00 | |
10 mg | In stock | 180.00 | |
25 mg | In stock | 350.00 | |
50 mg | In stock | 540.00 | |
100 mg | In stock | 820.00 | |
1 mL * 10 mM (in DMSO) | In stock | 102.00 |
Description | CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc. |
Targets&IC50 | HER2/ErbB2 :ic50 10nM, |
In vivo | CP-724714 (25 mg/kg) is rapidly absorbed after p.o. administration and causes reduction of tumor erbB2 receptor phosphorylation after dosing in FRE-erbB2 or BT-474 xenografts. CP-724,714 induces apoptosis in FRE-erbB2 xenograft-bearing (s.c.) mice and shows 50% tumor growth inhibition at 50 mg/kg, without mortality or weight loss. In MDA-MB-453, MDA-MB-231, LoVo (colon), and Colo-205 (colon) xenografts, CP-724714 also has great antitumor activity. In BT-474 xenografts, CP-724714 (30/100 mg/kg) reduces the extracellular signal-regulated kinase and Akt phosphorylation. |
Synonyms | CP 724714 , CP-724714 |
Purity | 98.82% |
Molecular Weight | 469.54 |
Formula | C27H27N5O3 |
CAS No. | 383432-38-0 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 50 mg/mL
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.